Eliezer Van Allen
About Eliezer Van Allen
Dr. Eliezer Van Allen is an Assistant Professor of Medicine at Harvard Medical School, the Computational Director for the Center for Cancer Precision Medicine at Dana-Farber Cancer Institute, and Associate Member of the Broad Institute, and a Medical Oncologist at Dana-Farber/Partners Cancer Care. Dr. Van Allen’s research focuses on computational cancer genomics, the application of new technologies and algorithms for precision cancer medicine, and the study of resistance to cancer therapeutics, with a focus on prostate cancer. As both a genitourinary medical oncologist and a computational biologist, he uses his experiences in both patient care and translational science with specific expertise in clinical computational oncology to analyze and interpret molecular data in prostate cancer and other malignancies for clinically-focused questions. Dr. Van Allen’s research program includes genome discovery, algorithm development, and functional validation of biomarkers with a specific focus on immuno-oncology. He received his MD from the David Geffen School of Medicine at UCLA.
2013 PCF Young Investigator Award
2016 PCF Challenge Award